Community treatment of HIV-1: initial stage and asymptotic dynamics.
暂无分享,去创建一个
[1] D. Ho,et al. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.
[2] D. Richman,et al. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. , 1989, Science.
[3] Robert T. Schooley,et al. Prolonged Zidovudine Therapy in Patients With AIDS and Advanced AIDS-Related Complex , 1989 .
[4] R. M. May,et al. Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1 , 1991, Nature.
[5] Roy M. Anderson,et al. Mathematical Models and the Design of Public Health Policy: Hiv and Antiviral Therapy , 1993, SIAM Rev..
[6] S W Lagakos,et al. Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection , 1990 .
[7] V L Murphy,et al. Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. , 1991, The Journal of infectious diseases.
[8] M A Fischl,et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.
[9] D. Mack,et al. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT). , 1988, Annals of internal medicine.
[10] Ying-Hen Hsieh,et al. Modelling the effect of treatment and behavioral change in HIV transmission dynamics , 1994, Journal of mathematical biology.
[11] A. J. Hall. Infectious diseases of humans: R. M. Anderson & R. M. May. Oxford etc.: Oxford University Press, 1991. viii + 757 pp. Price £50. ISBN 0-19-854599-1 , 1992 .
[12] M A Fischl,et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.